Gene therapy may require multi-stage drug delivery systems
August 04, 2009 | Analyst Insight
At the SMi Controlled Release conference in London last week, we spoke with Andrew Miller, Director of the Imperial College London Genetic Therapies Centre. Andrew is working on “soft, triggerable nanoparticles” for...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.